“The higher rating reflects our view of Bon Secours’ healthy enterprise profile, characterized by its broad geographic coverage across six states and stable market position in each of its local markets, along with its incrementally improved financial profile, including consistent financial performance in recent years,” said S&P analyst Jennifer Soule.
The outlook is stable.
More articles on healthcare finance:
CHS’ largest shareholder donates $115M to Caltech for brain research
Outsourcing of complex claims is a trend set to expand, Black Book survey finds
UHS stock tumbles 12% after BuzzFeed investigative report
